Day: February 9, 2021

BOCA RATON, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (NASDAQ: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that a complaint filed on December 9, 2019 with the Circuit Court of the Fifteenth Judicial Circuit for Palm Beach County, Florida (“the Court”), Case No. 50-2019-CA-010026, has been dismissed in its entirety for failure to state a cause of action. The plaintiffs in this action had alleged that the Company’s registration statement related for its initial public offering contained material omissions and false or misleading statements. As Greenlane previously announced, a related case in the United States District Court for the Southern District...

Phase 2 Study of oral niclosamide planned for 1H 2021DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has entered into an agreement with PPD, Inc. (NASDAQ: PPD), a leading global contract research organization (CRO), for its planned Phase 2 clinical trial evaluating a proprietary formulation of micronized niclosamide as a treatment for COVID-19-associated gastrointestinal (GI) infections.  Under the terms of the agreement, PPD will manage the Phase 2 clinical trial for an immediate-release capsule formulation of micronized oral niclosamide, also known as FW-1022. Licensed by AzurRx in January...

Dantax halvårsrapport 1/7 – 31/12 2020Resume:Periodens resultat efter skat blev et overskud på 8,9 mio. kr., mod et overskud på 3,0 mio. kr. sidste år. Resultatet af primær drift udgør 410 t.kr. efter skat og resultatet af finansielle poster udgør 8.319 t.kr. efter skat. En del af selskabets overskydende likviditet er investeret i børsnoterede aktier. I halvåret har der i gennemsnit været investeret 60 mio. kr. i aktier. Investeringen har i halvåret givet et afkast på 10,9 mio.kr. før skat, svarende til et afkast på ca. 18,2 % for perioden. Forventningerne til årets resultat ændres til et overskud før finansielle poster i niveauet 0,5 – 1 mio. kr. efter skat, mod tidligere 0 – 1 mio. kr.Dantax A/SPeter Bøgh JensenCEOVedhæftet filDantax Halvaarsrapport 010720 311220

February 9, 2021Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring for USD 72.00 per share in cash. At 12:00 midnight, New York time, on February 9, 2021 (one minute after 11:59 P.M., New York time, on February 8, 2021), the Offer expired as scheduled and was not extended. Philips expects to complete the acquisition of BioTelemetry later today through a merger under Section 251(h) of the General Corporation Law of the State of Delaware.American Stock Transfer & Trust Company, LLC, the depositary for the Offer (the “Depositary”), has...

Awilco Drilling PLC’s Fourth Quarter 2020 report will be released prior to market opening on Wednesday 10 February 2021. A digital presentation will be held on 10 February 2021 at 11:00 UK time (12:00pm CET / 06:00 EST). The presentation will be available for download on the Investor Relations section (go to “Press Releases”) at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation.To join the digital meeting, please click this link or copy and paste the following address into your browser:https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDU1M2ZkMzYtNjQwNi00NTU1LTg5OTctM2IzMjUxMmY3Y2Iy%40thread.v2/0?context=%7b%22Tid%22%3a%22c6903860-15d6-4675-a5fe-cf03764de020%22%2c%22Oid%22%3a%22b70a3a9b-a081-41f9-b2a4-3e57ef82979e%22%2c%22IsBroadcastMeeting%22%3atrue%7dA replay of the...

TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the appointment of Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee as the principal investigator for its planned FDA registration trial for CGuard EPS.“InspireMD is extremely fortunate to have Chris Metzger enthusiastically agree to shepherd the CGuard clinical trial. Chris is an extremely skilled, high volume cardiovascular and carotid stent operator. He is also a highly regarded mentor and educator. His vast clinical trial experience will bring strong leadership to this landmark FDA study,” stated Gary Roubin, M.D., Ph.D., InspireMD Director and internationally...

VIRGINIA BEACH, Va., Feb. 09, 2021 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) announced that its Board of Directors declared a cash dividend of $0.15 per common share for the first quarter of 2021. This represents a 36% increase over the prior quarter’s cash dividend. The first quarter cash dividend will be payable on April 8, 2021 to stockholders of record on March 31, 2021. The first quarter cash dividend will be payable on April 8, 2021 to stockholders of record on March 31, 2021.The Board of Directors also declared a cash dividend of $0.421875 per share on its 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock payable on April 15, 2021 to stockholders of record on April 1, 2021.“We appreciate the confidence the Board has shown by substantially increasing the first quarter dividend,” said Louis...

For the year, cash flows from operating activities were $1.8 billion, up 64% compared to $1.1 billion in the prior yearFor the year, free cash flow almost doubled to $1.6 billion compared to $835 million in the prior yearRevenue1increased 3% for both the quarter and the yearOrganic revenue growth of 2% for both the quarter and the yearDiluted Earnings per Share were $3.66 for the quarter, down 12% over prior yearDiluted Earnings per Share were $7.65 for the year, down 5% over prior yearAdjusted Diluted Earnings per Share were $5.23 for the quarter, up 7% over prior yearAdjusted Diluted Earnings per Share were $11.70 for the year, up 7% over prior yearARLINGTON, Va. and LONDON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW) (the “Company”), a leading global advisory, broking and solutions company, today announced...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICESVANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) — Tantalus Systems Holding Inc. (formerly, RiseTech Capital Corp.) (“Tantalus” or the “Company”), is pleased to announce the start of trading today at the opening of the TSX Venture Exchange under the ticker symbol “GRID”.The start of trading of the Company is in connection with its previously announced acquisition of all of the issued and outstanding shares of Tantalus Systems Holding Inc. on January 29, 2021 pursuant to an Arrangement Agreement and corresponding Plan of Arrangement, such transaction constituting the ‘Qualifying Transaction’ of the Company pursuant to the polices of the TSX Venture Exchange.About Tantalus Systems Holding Inc.Over the past three decades, the Company, through Tantalus...

CALGARY, Alberta, Feb. 09, 2021 (GLOBE NEWSWIRE) — Husky Energy Inc., a wholly-owned subsidiary of Cenovus Energy Inc., will be filing today its 2020 fourth quarter and annual audited consolidated financial statements, Management’s Discussion & Analysis and Annual Information Form with Canadian securities regulatory authorities. These documents will be available on SEDAR at sedar.com and on the Husky website at huskyenergy.com. Husky will also be filing today its Annual Report on Form 40-F for the year ended December 31, 2020 with the United States Securities and Exchange Commission. This document will be available on EDGAR at sec.gov and on the Husky website.Investor and Media Inquiries:Jenna Pickering, Investor Relations403-750-1882Kim Guttormson, Media403-298-7088